|
🐜
|
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
201 auth.
R. Kate Kelley,
M. Ueno,
C. Yoo,
Richard S Finn,
J. Furuse,
Z. Ren,
T. Yau,
H. Klümpen,
Stephen L Chan,
M. Ozaka,
C. Verslype,
M. Bouattour,
Joon-Oh Park,
O. Barajas,
U. Pelzer,
...
J. Valle,
Li Yu,
U. Malhotra,
A. Siegel,
J. Edeline,
A. Vogel,
M. Akce,
Inmaculada Ales Diaz,
G. Alves,
Sumitra Anand,
Ç. Arslan,
J. Asselah,
E. Assenat,
F. Aubin,
L. Bai,
Y. Bai,
Susan Bates,
S. Begbie,
I. Ben-Aharon,
Nina Beri,
M. Berres,
J. Blanc,
I. Borbath,
R. Bordonaro,
G. Brandi,
Adam H. Burgoyne,
Kritiya Butthongkomvong,
M. Camandaroba,
Ke Cao,
M. Carballido,
Stephan Lam Chan,
Jen‐Shi Chen,
Ming-Huang Chen,
Xiaoming Chen,
A. Cheng,
T. Chiu,
Hye Jin Choi,
H. Chon,
J. Collignon,
A. C. Gracián,
Sarah Davis,
Ricardo Saraiva de Carvalho,
D. J. Groot,
A. Demols,
J. Vos,
M. Diab,
J. Easaw,
M. Eatock,
Rawad Elias,
F. Eskens,
A. Falcone,
P. Fernández,
Richard S Finn,
F. Franke,
M. Furukawa,
O. Gbolahan,
K. Geboes,
Keri-Lee Geneser,
Zhimin Geng,
R. Geva,
R. Gillmore,
T. Goetze,
Hongfeng Gou,
J. Grasselli,
S. Gu,
M. Gumus,
N. H. Mohammad,
C. Hao,
H. Harputluoglu,
H. Hatoum,
V. Heinemann,
W.K. Ho,
C. Hsu,
A. Hubert,
J. Hwang,
M. Inanc,
S. Iseas,
Vaishnavi Jeyasingam,
P. Fonseca,
W. Joubert,
J. Juengsamarn,
D. Kaen,
Masashi Kanai,
Stefan Kasper-Virchow,
G. Kazemi,
F. Kelleher,
R. Kate Kelley,
Jin Won Kim,
Jong Gwang Kim,
A. Abrahao,
H. Klumpen,
M. Kochenderfer,
F. Kose,
Ho-Ching Lam,
Choong-kun Lee,
Hyun Woo Lee,
Margaret Lee,
Myung Ah Lee,
W. Lee,
S. Sourd,
Dongliang Li,
Wei Li,
Houjie Liang,
T. Liang,
Chun Sen Lim,
B. Lingerfelt,
Charles A. Lopez,
J. Low,
T. M. Mercadé,
D. Malka,
Y. Mao,
G. Masi,
S. McCune,
R. McDermott,
E. Mcwhirter,
G. Mendez,
M. Milella,
Nobumasa Mizuno,
T. Mizutani,
C. Moniz,
Luisa Morales,
A. J. M. Martín,
B. Nervi,
N. Ngamphaiboon,
S. Oh,
B. Oksuzoglu,
D. Outlaw,
M. Ozguroglu,
O. Ozyılkan,
C. Painemal,
Yueyin Pan,
Chuang Peng,
C. Pétorin,
D. Pezet,
D. Power,
S. Qin,
A. Roohullah,
Hyewon Ryu,
P. Salman,
Mitsuhito Sasaki,
R. Sasidharan,
T. Satoh,
K. Schulze,
M. Scott-Brown,
Rubén Segovia,
Thomas Seufferlein,
Salvatore Siena,
I. Sinapi,
C. Smolenschi,
T. Song,
A. Sookprasert,
N. Soparattanapaisarn,
N. Starling,
S. Stein,
S. Stemmer,
Haichuan Su,
R. Sugimoto,
T. Suksombooncharoen,
V. Tam,
Ai Lian Tan,
C. Tan,
S. Tanasanvimon,
G. Tonini,
G. Tortora,
A. Tsuji,
Rodrigo Uribe,
M. Venerito,
H. Mata,
A. Victorino,
J. Wade,
D. Waldschmidt,
Lulu Wang,
Wan Zamaniah Wan Isahk,
Harpeet Wasan,
R. Weschenfelder,
Chun-yin Louisa Wong,
Y. F. Wong,
Ş. Yalçın,
P. Weber,
Xuezhong Yang,
H. Yasui,
O. Yazıcı,
C. Yen,
J. Ying,
Wenchang Yu,
Haitao Zhao
|
8 |
2023 |
8
🐜
|
|
🐜
|
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
102 auth.
S. Qin,
S. Chan,
S. Gu,
Y. Bai,
Z. Ren,
Xiaoyan Lin,
Zhendong Chen,
W. Jia,
Yongdong Jin,
Ya-bing Guo,
Xiaohua Hu,
Z. Meng,
Jun Liang,
Ying Cheng,
Jianping Xiong,
...
H. Ren,
Fan Yang,
W. Li,
Yajin Chen,
Yong Zeng,
A. Sultanbaev,
M. Pazgan-Simon,
M. Pisetska,
D. Melisi,
Dmitriy Ponomarenko,
Yurii Osypchuk,
I. Sinielnikov,
Tsai‐Sheng Yang,
Xiao Liang,
Chunxia Chen,
Linna Wang,
A. Cheng,
A. Kaseb,
A. Vogel,
Mingxiang Zhang,
Li Xu,
Xianglin Yuan,
Da Li,
Jierer Ying,
Jingdong Zhang,
Tao Zhang,
K. Gu,
Yifu He,
Ping Hao,
D. Jiang,
Shu Zhang,
B. Xing,
Baihong Zhang,
Dong Wang,
Xiaofeng Zhai,
Houjie Liang,
B. Cybulska-Stopa,
M. Dvorkin,
D. Stroyakovskiy,
M. Nechaeva,
C. Yen,
W. Su,
Yen Chen,
I. Bondarenko,
Lin Yang,
W. Fang,
C. Gómez-Martín,
M. Ryu,
Han-Sang Kim,
Jee-Hyun Kim,
Oleg Zarubenkov,
R. Orlova,
E. Poddubskaya,
N. Fadeeva,
Y. Makarova,
Y. Chao,
Chao-Hung Hung,
Maryna Neffa,
O. Vynnychenko,
Adam M. Burgoyne,
C. Hao,
R. Mohr,
R. Diaz-Beveridge,
Jaime Feliú-Batlle,
Antonio Cubillo-Gracian,
A. Lee,
B. Daniele,
L. Antonuzzo,
A. Sangiovanni,
A. Gasbarrini,
M. Scartozzi,
M. Ahn,
S. Oh,
S. Orlov,
H. Harputluoglu,
B. Oksuzoglu,
Chiun Hsu,
K. Rau,
Oleksandr Krechkovskyi,
Vladimir Yareshko,
H. Xiong,
F. Lee,
Yixing Jiang,
A. Gabayan,
Mary Crow,
C. Steenkiste,
G. Verset
|
7 |
2023 |
7
🐜
|
|
🐜
|
Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival
7 auth.
F. Turkoz,
M. Solak,
S. Kılıçkap,
A. Ulaş,
O. Eşbah,
B. Oksuzoglu,
...
Ş. Yalçın
|
6 |
2014 |
6
🐜
|
|
🐢
|
Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients
14 auth.
A. Durnalı,
N. Alkiş,
Sengul Cangur,
F. Yukruk,
A. Inal,
S. Tokluoğlu,
M. Şeker,
O. Bal,
T. Akman,
M. Inanc,
...
A. Işıkdoğan,
A. Demirci,
K. Helvacı,
B. Oksuzoglu
|
6 |
2013 |
6
🐢
|
|
🐢
|
Metaplastic breast carcinoma: case series and review of the literature.
10 auth.
O. Eşbah,
F. Turkoz,
I. Turker,
A. Durnalı,
A. Ekinci,
O. Bal,
...
O. Sonmez,
B. Budakoğlu,
U. Arslan,
B. Oksuzoglu
|
6 |
2012 |
6
🐢
|
|
🐜
|
Breast cancer subtypes and outcomes of central nervous system metastases.
10 auth.
U. Arslan,
B. Oksuzoglu,
S. Aksoy,
H. Harputluoglu,
I. Turker,
Y. Ozişik,
...
O. Dizdar,
K. Altundağ,
N. Alkiş,
N. Zengi̇n
|
5 |
2011 |
5
🐜
|
|
🐜
|
Prognostic factors and clinical outcome of patients with Ewing’s sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology
13 auth.
E. Arpacı,
T. Yeti̇şyi̇ği̇t,
M. Şeker,
D. Uncu,
U. Uyeturk,
B. Oksuzoglu,
U. Demirci,
U. Coşkun,
M. Kucukoner,
A. Işıkdoğan,
...
M. Inanc,
N. Alkiş,
M. Ozkan
|
5 |
2013 |
5
🐜
|
|
🐜
|
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)
17 auth.
B. Cetin,
M. Benekli,
I. Turker,
L. Koral,
A. Ulaş,
F. Dane,
B. Oksuzoglu,
M. Kaplan,
D. Koca,
C. Boruban,
...
Burçak Yılmaz,
A. Sevinç,
V. Berk,
D. Uncu,
H. Harputluoglu,
U. Coşkun,
S. Buyukberber
|
5 |
2014 |
5
🐜
|
|
🐜
|
A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer
7 auth.
A. Ulaş,
F. Turkoz,
K. Sılay,
S. Tokluoğlu,
N. Avcı,
B. Oksuzoglu,
...
N. Alkiş
|
5 |
2014 |
5
🐜
|
